Literature DB >> 20107091

Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates.

Niamh M Cooke1, Stephen G Smith, Mary Kelleher, Thomas R Rogers.   

Abstract

Escherichia coli is a major cause of bloodstream infections and death due to sepsis. It is the most frequent Gram-negative bacterial pathogen recovered from cultures of blood from both community-acquired and nosocomial cases. We set out to determine the relationships between E. coli virulence factors (VFs), phylogenetic groups, and antibiotic resistance and whether bacteremia cases had a community, health care-associated. or nosocomial origin. Isolates from consecutive episodes of E. coli bacteremia in 303 patients presenting to a university hospital were screened for their VFs, phylogenetic group, and antibiotic resistance. The majority of VFs present in the collection were equally distributed between antibiotic-susceptible and multiple-drug-resistant (MDR) isolates, but the overall VF score was higher for isolates of community and health care-associated origin than those of nosocomial origin (P = 0.0002 and P = 0.0172, respectively); the papA, papG allele II, hlyA, and hek VFs were more prevalent in this cohort. Most isolates belonged to phylogenetic group B2, which harbored a greater proportion of antibiotic-susceptible isolates than MDR isolates (P = 0.04). The community, health care-associated, or nosocomial origin of E. coli bacteremia determines the virulence capacity of an isolate better than the phylogenetic group does. This study provides new insights into the relationships between the pathogenesis and epidemiology of E. coli bacteremia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107091      PMCID: PMC2849620          DOI: 10.1128/JCM.02017-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Ronald N Jones
Journal:  Semin Respir Crit Care Med       Date:  2003-02       Impact factor: 3.119

2.  High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups.

Authors:  Matija Rijavec; Marjanca Starcic Erjavec; Jerneja Ambrozic Avgustin; Rolf Reissbrodt; Angelika Fruth; Veronika Krizan-Hergouth; Darja Zgur-Bertok
Journal:  Curr Microbiol       Date:  2006-06-26       Impact factor: 2.188

3.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains.

Authors:  Martine Bingen-Bidois; Olivier Clermont; Stéphane Bonacorsi; Mustapha Terki; Naïma Brahimi; Chawki Loukil; Dominique Barraud; Edouard Bingen
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Daniel F Sahm; James A Karlowsky
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

6.  Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects.

Authors:  Mark R Sannes; Michael A Kuskowski; Krista Owens; Abby Gajewski; James R Johnson
Journal:  J Infect Dis       Date:  2004-11-15       Impact factor: 5.226

7.  The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.

Authors:  Olivier Clermont; Marie Lavollay; Sophie Vimont; Catherine Deschamps; Christiane Forestier; Catherine Branger; Erick Denamur; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2008-03-11       Impact factor: 5.790

8.  Antimicrobial susceptibility of 136 Escherichia coli isolates from cases of neonatal meningitis and relationship with virulence.

Authors:  V Houdouin; S Bonacorsi; P Bidet; E Bingen
Journal:  Clin Microbiol Infect       Date:  2007-10-19       Impact factor: 8.067

9.  Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.

Authors:  Majdi N Al-Hasan; Brian D Lahr; Jeanette E Eckel-Passow; Larry M Baddour
Journal:  J Antimicrob Chemother       Date:  2009-05-12       Impact factor: 5.790

10.  Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.

Authors:  Galo Peralta; M Blanca Sánchez; J Carlos Garrido; Inés De Benito; M Eliecer Cano; Luis Martínez-Martínez; M Pía Roiz
Journal:  J Antimicrob Chemother       Date:  2007-07-20       Impact factor: 5.790

View more
  23 in total

1.  Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model.

Authors:  Holly Ciesielczuk; Jonathon Betts; Lynnette Phee; Michel Doumith; Russell Hope; Neil Woodford; David W Wareham
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  The heat-resistant agglutinin family includes a novel adhesin from enteroaggregative Escherichia coli strain 60A.

Authors:  Justin Mancini; Brooke Weckselblatt; Yoonjie K Chung; Julia C Durante; Steven Andelman; Jessica Glaubman; Justin D Dorff; Samhita Bhargava; Rebeccah S Lijek; Katherine P Unger; Iruka N Okeke
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

3.  Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.

Authors:  Rebecca I Waltner-Toews; David L Paterson; Zubair A Qureshi; Hanna E Sidjabat; Jennifer M Adams-Haduch; Kathleen A Shutt; Mark Jones; Guo-Bao Tian; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

4.  Involvement of virulence properties and antibiotic resistance in Escherichia coli strains causing pyelonephritis in children.

Authors:  Ján Koreň; Katarína Čurová; Marta Kmeťová; Leonard Siegfried; Viktor Jankó; László Kovács; Helena Hupková; Ján Luha
Journal:  Folia Microbiol (Praha)       Date:  2012-06-21       Impact factor: 2.099

Review 5.  Escherichia coli pyomyositis in an immunocompromised host.

Authors:  Umesh Sharma; William R Schwan; William A Agger
Journal:  WMJ       Date:  2011-08

6.  Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Authors:  Yanping Luo; Yanning Ma; Qiang Zhao; Leili Wang; Ling Guo; Liyan Ye; Youjiang Zhang; Jiyong Yang
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.

Authors:  F Freitas; E Machado; T G Ribeiro; Â Novais; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-07       Impact factor: 3.267

8.  Uropathogenic Escherichia coli isolates from pregnant women in different countries.

Authors:  Nubia L Ramos; Musa Sekikubo; Dang Thi Ngoc Dzung; Corinna Kosnopfel; Fred Kironde; Florence Mirembe; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2012-08-22       Impact factor: 5.948

9.  Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Authors:  V Pascual; N Alonso; M Simó; G Ortiz; M C Garcia; M Xercavins; A Rivera; M A Morera; E Miró; E Espejo; F Navarro; M Gurguí; J Pérez; M Rodríguez-Carballeira; J Garau; E Calbo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-22       Impact factor: 3.267

10.  Molecular characterization of bacteremic Escherichia coli isolates in Romania.

Authors:  Codruţa-Romaniţa Usein; Raluca Papagheorghe; Mihaela Oprea; Maria Condei; Monica Strãuţ
Journal:  Folia Microbiol (Praha)       Date:  2015-10-09       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.